|
ASCC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.828800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.756000E-01 |
| Normal-vs-Stage2 |
4.555000E-01 |
| Normal-vs-Stage3 |
3.414400E-01 |
| Normal-vs-Stage4 |
3.350400E-01 |
| Stage1-vs-Stage2 |
3.148200E-01 |
| Stage1-vs-Stage3 |
1.513830E-01 |
| Stage1-vs-Stage4 |
2.352800E-01 |
| Stage2-vs-Stage3 |
9.739400E-01 |
| Stage2-vs-Stage4 |
9.187000E-01 |
| Stage3-vs-Stage4 |
9.287800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.748400E-01 |
| Normal-vs-AfricanAmerican |
4.655000E-01 |
| Normal-vs-Asian |
9.701600E-01 |
| Caucasian-vs-AfricanAmerican |
3.048400E-01 |
| Caucasian-vs-Asian |
7.294800E-01 |
| AfricanAmerican-vs-Asian |
5.060400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.562200E-01 |
| Normal-vs-Female |
5.851600E-01 |
| Male-vs-Female |
3.230600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.909200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.834200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.694600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.543000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.589430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.916000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.894400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.357000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.192000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.998400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.639970E-01 |
| Classical-VS-Follicular |
3.641900E-02 |
| Classical-VS-Other |
4.440000E-01 |
| Classical-VS-Normal |
6.670200E-01 |
| Tall-VS-Follicular |
8.503600E-01 |
| Tall-VS-Other |
9.560400E-01 |
| Tall-VS-Normal |
3.226400E-01 |
| Follicular-VS-Other |
9.699200E-01 |
| Follicular-VS-Normal |
1.904820E-01 |
| Other-VS-Normal |
5.438200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.599400E-01 |
| Normal-vs-N1 |
1.677230E-01 |
| N0-vs-N1 |
3.589800E-01 |
|
|
